QNTM QUANTUM BIOPHARMA LTD
FollowCL B SUB VTG SHS (common), issuer CIK 1771885
18 managers (18 13F filers) reported a position in QNTM shares at 2025-06-30, 116,515 shares in all. 6 filers opened a position and 3 filers sold out during the quarter.
- Managers
- 18
- 13F filers
- 18
- New
- 6
- Added
- 3
- Reduced
- 5
- Sold out
- 3
- Shares held by filers
- 116,515
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- AdvisorShares Trust
400,378 shares, 4.95% in a 13G/A as of 2026-09-30,0000929638-26-003843
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q2 2025
Filers in the available 13F reports with a share position at 2025-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
Events
AdvisorShares Trust reported 400,378 QNTM shares, 4.95% of the class, as of 2026-09-30, in a 13G/A filed 2026-10-05. 0000929638-26-003843
Accepted , ingested